<i>FLTX2</i>: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties

Tamoxifen is the most widely used selective modulator of estrogen receptors (SERM) and the first strategy as coadjuvant therapy for the treatment of estrogen-receptor (ER) positive breast cancer worldwide. In spite of such success, tamoxifen is not devoid of undesirable effects, the most life-threat...

Full description

Bibliographic Details
Main Authors: Mario Díaz, Fernando Lobo, Dácil Hernández, Ángel Amesty, Catalina Valdés-Baizabal, Ana Canerina-Amaro, Fátima Mesa-Herrera, Kevin Soler, Alicia Boto, Raquel Marín, Ana Estévez-Braun, Fernando Lahoz
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/10/5339